Marshall H. Woodworth serves as Executive at Furiex Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Marshall H. Woodworth has executed 5 insider transactions totaling $91.8K, demonstrating a bullish approach to their equity position. Their most recent transaction on Jan 23, 2026 involved receiving (via award) 28,000 shares valued at $0.
Marshall H. Woodworth currently holds 30,734 shares of Furiex Pharmaceuticals, Inc. (FURX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Marshall H. Woodworth has been a net buyer of FURX stock. They have purchased $91.8K and sold $0 worth of shares.
Marshall H. Woodworth's most recent insider trade was on Jan 23, 2026, when they sold 28,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Mar 1, 2024 | NRBO | $0 | Award | 33,496 | $N/A | Discretionary |
| Jun 10, 2013 | FURX | $0 | Award | 10,200 | $N/A | Discretionary |
| Nov 4, 2011 | FURX | $91.8K | Purchase | 6,211 | $14.78 | Discretionary |